Riahi Vahid, Diouf Ibrahima, Khanna Sankalp, Boyle Justin, Hassanzadeh Hamed
Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Melbourne, Australia.
Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Australia.
J Med Internet Res. 2025 Jan 8;27:e55015. doi: 10.2196/55015.
The health care industry must align with new digital technologies to respond to existing and new challenges. Digital twins (DTs) are an emerging technology for digital transformation and applied intelligence that is rapidly attracting attention. DTs are virtual representations of products, systems, or processes that interact bidirectionally in real time with their actual counterparts. Although DTs have diverse applications from personalized care to treatment optimization, misconceptions persist regarding their definition and the extent of their implementation within health systems.
This study aimed to review DT applications in health care, particularly for clinical decision-making (CDM) and operational decision-making (ODM). It provides a definition and framework for DTs by exploring their unique elements and characteristics. Then, it assesses the current advances and extent of DT applications to support CDM and ODM using the defined DT characteristics.
We conducted a scoping review following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) protocol. We searched multiple databases, including PubMed, MEDLINE, and Scopus, for original research articles describing DT technologies applied to CDM and ODM in health systems. Papers proposing only ideas or frameworks or describing DT capabilities without experimental data were excluded. We collated several available types of information, for example, DT characteristics, the environment that DTs were tested within, and the main underlying method, and used descriptive statistics to analyze the synthesized data.
Out of 5537 relevant papers, 1.55% (86/5537) met the predefined inclusion criteria, all published after 2017. The majority focused on CDM (75/86, 87%). Mathematical modeling (24/86, 28%) and simulation techniques (17/86, 20%) were the most frequently used methods. Using International Classification of Diseases, 10th Revision coding, we identified 3 key areas of DT applications as follows: factors influencing diseases of the circulatory system (14/86, 16%); health status and contact with health services (12/86, 14%); and endocrine, nutritional, and metabolic diseases (10/86, 12%). Only 16 (19%) of 86 studies tested the developed system in a real environment, while the remainder were evaluated in simulated settings. Assessing the studies against defined DT characteristics reveals that the developed systems have yet to materialize the full capabilities of DTs.
This study provides a comprehensive review of DT applications in health care, focusing on CDM and ODM. A key contribution is the development of a framework that defines important elements and characteristics of DTs in the context of related literature. The DT applications studied in this paper reveal encouraging results that allow us to envision that, in the near future, they will play an important role not only in the diagnosis and prevention of diseases but also in other areas, such as efficient clinical trial design, as well as personalized and optimized treatments.
医疗保健行业必须与新的数字技术相结合,以应对现有和新出现的挑战。数字孪生(DTs)是一种用于数字转型和应用智能的新兴技术,正迅速引起关注。数字孪生是产品、系统或流程的虚拟表示,与它们的实际对应物进行实时双向交互。尽管数字孪生在从个性化护理到治疗优化等方面有多种应用,但对于其定义以及在卫生系统中的实施程度仍存在误解。
本研究旨在回顾数字孪生在医疗保健中的应用,特别是用于临床决策(CDM)和运营决策(ODM)。通过探索其独特的要素和特征,为数字孪生提供定义和框架。然后,利用所定义的数字孪生特征评估支持临床决策和运营决策的数字孪生应用的当前进展和程度。
我们按照PRISMA - ScR(系统评价和Meta分析扩展版的系统评价优先报告项目)协议进行了一项范围综述。我们在多个数据库中进行搜索,包括PubMed、MEDLINE和Scopus,以查找描述应用于卫生系统中临床决策和运营决策的数字孪生技术的原始研究文章。仅提出想法或框架或描述数字孪生能力而无实验数据的论文被排除。我们整理了几种可用的信息类型,例如数字孪生特征、测试数字孪生的环境以及主要的基础方法,并使用描述性统计分析综合数据。
在5537篇相关论文中,1.55%(86/5537)符合预定义的纳入标准,所有论文均在2017年之后发表。大多数论文聚焦于临床决策(75/86,87%)。数学建模(24/86,28%)和模拟技术(17/86,20%)是最常用的方法。使用国际疾病分类第十次修订版编码,我们确定了数字孪生应用的3个关键领域如下:影响循环系统疾病的因素(14/86,16%);健康状况以及与卫生服务的接触(12/86,14%);以及内分泌、营养和代谢疾病(10/86,12%)。86项研究中只有16项(19%)在真实环境中测试了所开发的系统,其余研究在模拟环境中进行评估。根据所定义的数字孪生特征评估这些研究表明,所开发的系统尚未实现数字孪生的全部功能。
本研究对数字孪生在医疗保健中的应用进行了全面综述,重点关注临床决策和运营决策。一个关键贡献是开发了一个框架,在相关文献的背景下定义了数字孪生的重要要素和特征。本文研究的数字孪生应用显示出令人鼓舞的结果,使我们能够设想,在不久的将来,它们不仅将在疾病的诊断和预防中发挥重要作用,还将在其他领域发挥重要作用,如高效的临床试验设计以及个性化和优化治疗。